Target intelligence / Profile preview

RNA, U1 small nuclear 56, pseudogene (RNU1-56P)

Target
RNU1-56P
Molecular classification
Small nuclear RNA pseudogene, Non-coding RNA, Other
01

Overview

RNU1-56P (RNA, U1 small nuclear 56, pseudogene) is a human pseudogene belonging to the small nuclear RNA (snRNA) family, specifically annotated as a U1 snRNA pseudogene[1][3]. Genuine U1 small nuclear RNAs are key components of the spliceosome machinery, involved in the recognition of 5’ splice sites and initiation of pre-mRNA splicing. However, as a pseudogene, RNU1-56P is a genomic sequence similar to U1 snRNA genes but is considered non-functional and is not known to produce a functional RNA product or protein[1][3]. There are no established biological functions, disease roles, or drug interactions attributed to this pseudogene. It is not considered a therapeutic target. Key details and rationale: - RNU1-56P is explicitly described as a pseudogene in authoritative gene databases[1][3]. - Small nuclear RNA pseudogenes do not encode proteins and generally do not produce functional RNAs; hence, they are not targets for therapeutic drugs or biomarker applications[1][3][6]. - No literature supports a role for RNU1-56P in disease, therapeutics, or as a biomarker. - The canonical gene for functional U1 snRNA is RNU1-1 (or variants such as RNU1-2); RNU1-56P should not be confused with these functional genes[2][5]. - The molecular classification as a small nuclear RNA pseudogene is based on the nomenclature maintained by HGNC and supporting genomics resources[1][3][6]. - Aliases are limited as the name is unique and standardized in major databases[1][3]. If you need information about the functional U1 small nuclear RNA (not the pseudogene), those molecules have roles in mRNA splicing and are considered important for gene expression regulation[2][5].

Other names
RNU1-56P

Beyond the preview

Go deeper on RNA, U1 small nuclear 56, pseudogene (RNU1-56P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 56, pseudogene (RNU1-56P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call